Medios AG
Overview
Medios AG is a leading provider of specialty pharmaceuticals in Europe. The company focuses on delivering innovative solutions and intelligent services to pharmacies, specialist practices, and pharmaceutical companies, aiming to make the most innovative pharmacotherapies accessible to everyone. Medios operates in Germany, the Netherlands, Belgium, and Spain, supporting key partners in the supply chain with its expertise. The company's investment strategy centers on growth, late-stage, and pre-IPO investments in the healthcare, pharmaceuticals, and biotechnology sectors. Medios seeks to invest in companies with sustainable EBITDA between EUR 2 million and EUR 10 million per annum, focusing on businesses with further organic sales growth potential. The company emphasizes long-term value creation and supports management teams in achieving jointly defined goals. Medios AG is Germany's first listed specialty pharmaceutical company, with shares listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard) and included in the SDAX selection index. The company has a track record of successfully establishing itself as the German market leader and achieving a leading position in Europe over the last decade. In May 2025, Medios announced a strategic repositioning to focus on profitability and value creation for shareholders, marking a new phase in its corporate development.
Investment Focus
- Sustainable EBITDA between EUR 2 million and EUR 10 million per annum
- Further organic sales growth potential
- Focus on healthcare, pharmaceuticals, and biotechnology sectors
Portfolio Companies
Reach Medios AG directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Medios AG
What sectors does Medios AG invest in?
Medios AG invests in Healthcare, Pharmaceuticals and Biotechnology, and is based in Berlin, Germany. Medios AG is listed as a private equity in the ConnectSafely investor database.
What stage does Medios AG invest at?
Medios AG backs companies at Growth, Late Stage and Pre-IPO, writing cheques of 5M - 50M.
Which regions does Medios AG invest in?
Medios AG invests across Germany, Spain, Netherlands and Belgium.
What companies has Medios AG invested in?
Medios AG's portfolio includes Medios Pharma, Medios Solutions, Medios Blister, Medios Individual, Medios Solutions Aschaffenburg, Medios Solutions Stuttgart, Medios Solutions Berlin and Medios Solutions Osnabrück.
Last updated · Source: ConnectSafely investor database
